Skip to Content

L474 (Ukoniq 200 mg)

Generic Name: umbralisib

Pill with imprint L474 is Green, Elliptical / Oval and has been identified as Ukoniq 200 mg. It is supplied by TG Therapeutics, Inc..

Ukoniq is used in the treatment of follicular lymphoma and belongs to the drug class multikinase inhibitors. Ukoniq 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L474

Ukoniq

Generic Name
umbralisib
Imprint
L474
Strength
200 mg
Color
Green
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
TG Therapeutics, Inc.
National Drug Code (NDC)
73150-0200

Get help with Imprint Code FAQs.

More about Ukoniq (umbralisib)

Consumer resources

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.